At5g45160 Antibody

What is the At5g45160 antibody and what organism does it target?

The At5g45160 antibody is a polyclonal antibody that specifically recognizes the At5g45160 protein from Arabidopsis thaliana (Mouse-ear cress). This antibody was generated by immunizing rabbits with recombinant Arabidopsis thaliana At5g45160 protein as the immunogen. The antibody has been produced as part of a larger effort to create antibody resources for functional studies in plants, specifically targeting key proteins in Arabidopsis roots. The antibody preparation is non-conjugated and exists in liquid form, making it suitable for various immunological applications. The antibody recognizes its target with high specificity, enabling researchers to detect the At5g45160 protein in complex biological samples within Arabidopsis thaliana systems .

How was the At5g45160 antibody developed and validated?

The At5g45160 antibody was developed using a recombinant protein approach rather than a synthetic peptide approach. The development followed a systematic pipeline that included target selection, bioinformatic analysis of the target protein, identification of antigenic regions, analysis of potential cross-reactivity, cloning of the target region, antibody production, purification, quality control, and validation. The recombinant protein approach was chosen because it demonstrated significantly higher success rates than the peptide approach in the developers' experience. Initial quality control was performed using dot blots against the recombinant protein, where most crude antisera could detect target proteins in the picogram range, indicating good antibody titer. Further validation typically involved affinity purification with purified recombinant protein, which significantly improved detection rates. Full validation would have included testing the antibody in both Western blot applications and immunolocalization studies, potentially utilizing corresponding mutant backgrounds to confirm specificity when available .

What are the optimal storage conditions for At5g45160 antibody to maintain its effectiveness?

The At5g45160 antibody should be stored at -20°C or -80°C upon receipt to maintain its effectiveness and activity. Researchers should avoid repeated freezing and thawing cycles as this can lead to antibody degradation and loss of binding capacity. The antibody is formulated in a storage buffer containing preservative (0.03% Proclin 300) and stabilizers (50% Glycerol, 0.01M PBS, pH 7.4), which helps maintain its structural integrity during storage. For long-term storage, it is advisable to make small aliquots of the antibody to minimize repeated freeze-thaw cycles when retrieving portions for experiments. When handling the antibody, researchers should work quickly and keep the antibody on ice when in use to prevent degradation. After thawing an aliquot, it can be stored at 4°C for short periods (generally 1-2 weeks), but returning it to -20°C or -80°C is recommended for periods of non-use exceeding this timeframe .

What are the validated applications for At5g45160 antibody and how should experimental conditions be optimized?

The At5g45160 antibody has been validated for Enzyme-Linked Immunosorbent Assay (ELISA) and Western Blot (WB) applications, making it suitable for protein detection and quantification in these contexts. For Western blot applications, researchers should optimize several parameters: blocking conditions (typically 5% non-fat dry milk or BSA in TBST), antibody dilution (starting with manufacturer's recommendations, typically 1:1000 to 1:5000), incubation time and temperature (overnight at 4°C or 1-2 hours at room temperature), and washing steps (generally 3-5 washes with TBST). For ELISA applications, optimization should focus on coating conditions, blocking parameters, antibody dilution, and detection system sensitivity. In both applications, it's crucial to include appropriate positive and negative controls to validate results. While immunocytochemistry applications weren't explicitly listed for this antibody, the research indicates that many recombinant protein-derived antibodies showed promise in such applications, so researchers may consider testing it for immunolocalization studies after thorough validation in controlled experiments .

How can At5g45160 antibody be used effectively in Western blot applications?

For effective use of At5g45160 antibody in Western blot applications, researchers should follow a methodical protocol while optimizing specific conditions. Begin by preparing protein extracts from Arabidopsis thaliana tissues, ensuring proper protein denaturation using an appropriate lysis buffer containing protease inhibitors. Separate proteins using SDS-PAGE with recommended protein loads of 20-50 μg per lane, followed by transfer to a PVDF or nitrocellulose membrane. Block the membrane using 5% non-fat dry milk or BSA in TBST buffer for 1 hour at room temperature. Incubate the membrane with the At5g45160 antibody at an optimized dilution (starting with 1:1000 to 1:5000) in blocking buffer overnight at 4°C. Wash the membrane thoroughly (4-5 times with TBST, 5 minutes each) before applying an appropriate HRP-conjugated secondary antibody (anti-rabbit IgG) at the recommended dilution for 1-2 hours at room temperature. After additional washing steps, develop the signal using chemiluminescent substrate and image the membrane. For validation, researchers should confirm detection of a band at the expected molecular weight for At5g45160 and consider using wild-type versus mutant Arabidopsis samples as positive and negative controls to confirm specificity .

What considerations should be made when using At5g45160 antibody for protein localization studies?

When using At5g45160 antibody for protein localization studies, researchers should consider several critical factors to ensure robust and reliable results. First, tissue preparation is crucial - samples should be properly fixed (typically with 4% paraformaldehyde) and permeabilized to allow antibody access while preserving protein localization and tissue morphology. The antibody dilution must be optimized through titration experiments, typically starting with 1:100 to 1:500 dilutions. Background signal should be minimized through appropriate blocking (3-5% BSA or normal serum) and inclusion of detergents like Triton X-100 or Tween-20 in wash buffers. Specificity controls are essential, ideally using tissues from At5g45160 knockout mutants as negative controls. For co-localization studies, researchers should consider using established subcellular markers alongside the At5g45160 antibody, such as BiP (endoplasmic reticulum), γ-cop (Golgi), PM-ATPase (plasma membrane), or MDH (plastid), which have been developed as part of the same antibody resource collection. Signal amplification methods might be necessary if the target protein is expressed at low levels, potentially using tyramide signal amplification or other enhancement techniques .

How can researchers validate the specificity of At5g45160 antibody in their experimental systems?

Researchers can validate the specificity of At5g45160 antibody through multiple complementary approaches. The most definitive validation method involves comparing antibody detection in wild-type Arabidopsis samples versus At5g45160 knockout or knockdown mutants, where a specific antibody should show significantly reduced or absent signal in the mutant samples. If genetic knockout lines are unavailable, researchers can employ RNA interference (RNAi) or CRISPR-based approaches to reduce target protein expression, then confirm corresponding reductions in antibody signal. Competition assays represent another validation method, where pre-incubating the antibody with purified recombinant At5g45160 protein should eliminate specific binding in subsequent assays. Western blot analysis should demonstrate detection of a single band of the expected molecular weight, while mass spectrometry analysis of immunoprecipitated proteins can confirm the identity of the detected protein. Additionally, researchers should test for cross-reactivity with related proteins, especially important in multigene families, by expressing these proteins in heterologous systems and determining if the antibody recognizes them .

What quality control measures should be implemented when using At5g45160 antibody across different experimental batches?

Implementing rigorous quality control measures when using At5g45160 antibody across different experimental batches is essential for generating reproducible and reliable results. Researchers should include consistent positive controls (samples known to express At5g45160) in every experiment to verify antibody performance and establish a baseline for comparison. Similarly, negative controls (At5g45160 knockout/knockdown samples when available) should be included to confirm specificity. Maintaining detailed records of antibody lot numbers, dilutions, incubation conditions, and detection parameters enables tracking of batch-to-batch variability. Standardization of protein extraction methods, sample loading amounts, and experimental conditions reduces technical variability. Researchers should consider generating standard curves with recombinant At5g45160 protein for quantitative applications to ensure linearity of detection across batches. Additionally, comparing new antibody batches with previously validated batches through side-by-side testing helps identify any significant variations in performance. Finally, implementing consistent image acquisition settings and quantification methods ensures that any observed differences reflect biological rather than technical variability .

What potential cross-reactivity issues might arise with At5g45160 antibody and how can they be addressed?

Potential cross-reactivity issues with At5g45160 antibody could arise if the antibody recognizes epitopes shared with other proteins in Arabidopsis or experimental systems. The development process for this antibody included bioinformatic analysis to identify unique antigenic regions with less than 40% sequence similarity to other proteins, which reduces but doesn't eliminate potential cross-reactivity. Researchers can address cross-reactivity concerns through several approaches: using genetic knockout lines as negative controls provides the most definitive assessment of specificity; performing Western blot analysis to confirm detection of a single band at the expected molecular weight; conducting immunoprecipitation followed by mass spectrometry to identify all proteins recognized by the antibody; testing the antibody against closely related proteins expressed in heterologous systems; and performing pre-absorption tests where the antibody is incubated with recombinant At5g45160 protein before use (specific signals should disappear after pre-absorption). Additionally, comparing results from multiple detection methods (e.g., Western blot and immunolocalization) can provide confidence in antibody specificity, as concordant results across methods suggest proper target recognition .

What are common issues encountered when using At5g45160 antibody in Western blot applications and how can they be resolved?

Researchers may encounter several common issues when using At5g45160 antibody in Western blot applications, each requiring specific troubleshooting approaches. Weak or absent signals might result from insufficient protein concentration, protein degradation, inefficient transfer, or inappropriate antibody dilution; these can be addressed by increasing protein loading, adding protease inhibitors during extraction, optimizing transfer conditions, and testing different antibody concentrations. High background can result from insufficient blocking, inadequate washing, or excessive antibody concentration; solutions include increasing blocking time/concentration, performing more rigorous washing steps, and diluting the antibody further. Multiple bands might indicate protein degradation, post-translational modifications, or cross-reactivity; researchers can address this by using fresh samples with protease inhibitors, considering the biological relevance of modifications, or further purifying the antibody through affinity methods. Inconsistent results between experiments often stem from variations in sample preparation, transfer efficiency, or detection methods; standardizing protocols and including positive controls in each experiment can improve reproducibility. For membrane proteins like At5g45160, incomplete denaturation or aggregation during sample preparation can cause poor migration; optimizing sample buffer composition and heating conditions can improve resolution of these challenging targets .

How can researchers optimize immunolocalization protocols when using At5g45160 antibody for subcellular localization studies?

Optimizing immunolocalization protocols with At5g45160 antibody requires systematic adaptation across multiple parameters. Fixation conditions significantly impact epitope preservation and accessibility—researchers should compare different fixatives (paraformaldehyde, glutaraldehyde, methanol) and durations to identify optimal conditions for At5g45160 detection while maintaining cellular architecture. Permeabilization methods require careful optimization, as excessive treatment can disrupt subcellular structures while insufficient permeabilization prevents antibody access; typically, detergents like 0.1-0.5% Triton X-100 or 0.05-0.1% Tween-20 are used, with concentration and duration determined empirically. Blocking conditions should be tested with various agents (BSA, normal serum, casein) at different concentrations (1-5%) to minimize background while preserving specific signals. Antibody concentration represents a critical parameter—researchers should perform dilution series (typically starting at 1:100-1:500) to identify the optimal concentration that maximizes specific signal while minimizing background. Incubation conditions (duration, temperature) should be systematically tested, with longer incubations at 4°C often providing better signal-to-noise ratios than shorter incubations at room temperature. Signal amplification methods (tyramide signal amplification, ABC systems) may be necessary if protein expression is low. Finally, appropriate controls should always be included, ideally using At5g45160 knockout tissues as negative controls and co-localization with established organelle markers to confirm subcellular distribution patterns .

What strategies can researchers employ to troubleshoot poor signal-to-noise ratios when using At5g45160 antibody?

Researchers can employ multiple strategies to troubleshoot poor signal-to-noise ratios when using At5g45160 antibody. First, affinity purification of the antibody against the recombinant protein can dramatically improve specificity, as crude antisera often contain non-specific antibodies that contribute to background. The research shows that affinity purification increased detection rates from very low to 55% for similar antibodies in the collection. Second, blocking conditions should be optimized by testing different blocking agents (BSA, normal serum, casein, non-fat dry milk) at various concentrations (3-5%) and durations (1-2 hours) to reduce non-specific binding. Third, washing protocols can be intensified by increasing the number of washes (5-6 times), duration (10 minutes each), and detergent concentration in wash buffers. Fourth, antibody dilution should be systematically titrated to identify the optimal concentration that maximizes specific signal while minimizing background. Fifth, sample preparation techniques should be refined to ensure appropriate fixation that preserves epitopes while allowing antibody access. Sixth, signal amplification methods like tyramide signal amplification can improve detection of low-abundance proteins without proportionally increasing background. Finally, alternative detection systems with different sensitivity levels should be compared, as some chromogenic or fluorescent detection methods may provide better signal-to-noise ratios depending on the specific experimental context .

How can At5g45160 antibody be used in combination with other techniques for comprehensive protein function studies?

The At5g45160 antibody can be integrated into multifaceted research approaches to elucidate protein function through complementary techniques. Researchers can combine immunoprecipitation using the At5g45160 antibody with mass spectrometry (IP-MS) to identify interacting protein partners, revealing functional networks and potential regulatory mechanisms. Chromatin immunoprecipitation (ChIP) applications are possible if At5g45160 has DNA-binding properties, allowing identification of genomic binding sites. The antibody can be used alongside fluorescent protein fusion studies, where localization patterns determined by immunohistochemistry with the antibody can be compared with GFP-tagged protein distribution to cross-validate findings and detect potential artifacts from either approach. Cell fractionation studies followed by Western blotting with At5g45160 antibody can precisely determine the subcellular distribution of the native protein across multiple compartments. For temporal studies, the antibody enables tracking of protein expression and localization changes during development or in response to environmental stimuli. Integration with genetic approaches, where phenotypic effects of At5g45160 mutations can be correlated with altered protein levels or localization detected by the antibody, provides comprehensive functional insights. Finally, the antibody can be used in proximity labeling studies combined with proteomics to identify proteins in close spatial proximity to At5g45160, revealing the protein's microenvironment .

What considerations should be made when using At5g45160 antibody for protein-protein interaction studies?

When using At5g45160 antibody for protein-protein interaction studies, researchers should consider several sophisticated methodological aspects. The antibody should first be validated for immunoprecipitation (IP) applications, confirming it can effectively capture native At5g45160 protein from Arabidopsis extracts under non-denaturing conditions that preserve protein-protein interactions. Extraction and IP buffer compositions critically influence interaction preservation—mild, non-ionic detergents (0.1-0.5% NP-40, Triton X-100) and physiological salt concentrations help maintain interactions while solubilizing membrane-associated complexes. Cross-linking approaches using formaldehyde or specialized cross-linkers can stabilize transient or weak interactions prior to immunoprecipitation. Control experiments are essential, including IgG negative controls and, ideally, IP from At5g45160 knockout lines to distinguish specific from non-specific interactions. For detecting known interaction partners, co-immunoprecipitation followed by Western blotting with antibodies against suspected interactors provides direct evidence. For discovering novel interactors, immunoprecipitation followed by mass spectrometry offers a comprehensive approach, though statistical analysis of multiple replicates is necessary to distinguish genuine interactors from background proteins. Alternative approaches include proximity-dependent biotin labeling methods (BioID, TurboID, or miniTurbo) that can capture even transient interactors by fusing a biotin ligase to At5g45160, followed by streptavidin purification and mass spectrometry identification of biotinylated proximal proteins .

How can At5g45160 antibody be utilized in quantitative proteomics approaches to study protein expression dynamics?

The At5g45160 antibody can be strategically utilized in several quantitative proteomics approaches to study protein expression dynamics with high precision and biological relevance. In absolute quantification (AQUA) approaches, researchers can use the antibody for immunoprecipitation of At5g45160 followed by targeted mass spectrometry comparison with isotope-labeled peptide standards, enabling precise determination of protein abundance across different conditions. For relative quantification across multiple samples, the antibody can be employed in immunoprecipitation workflows followed by label-free quantification, SILAC (Stable Isotope Labeling with Amino acids in Cell culture), or chemical labeling approaches like TMT (Tandem Mass Tags) or iTRAQ (isobaric Tags for Relative and Absolute Quantification). The antibody also enables selected reaction monitoring (SRM) or multiple reaction monitoring (MRM) mass spectrometry approaches for targeted quantification of At5g45160 in complex samples. To study differential expression across tissues or developmental stages, researchers can combine immunohistochemistry with the antibody and quantitative image analysis to measure spatial changes in protein abundance. For temporal studies, the antibody can be used in time-course Western blot analyses with appropriate loading controls and densitometry quantification. Additionally, researchers can develop quantitative ELISA assays using the At5g45160 antibody to measure protein levels across multiple samples in high-throughput formats. For studies of protein turnover and stability, pulse-chase experiments combined with immunoprecipitation using the antibody allow measurement of protein half-life under various conditions .

How does the approach used to generate At5g45160 antibody compare with other antibody production methods for plant proteins?

The approach used to generate the At5g45160 antibody through recombinant protein methods represents a significant improvement over peptide-based approaches for plant protein antibodies. Based on the provided information, the recombinant protein approach yielded a 55% success rate (38 out of 70 antibodies) in detecting target proteins with high confidence, whereas the peptide approach had an extremely low success rate with only one out of 24 antibodies working satisfactorily. The recombinant protein method involves producing a substantial portion of the target protein (typically ~100 amino acids) in bacteria, allowing for multiple epitopes to be presented during immunization, which increases the likelihood of generating antibodies that recognize the native protein conformation. In comparison, peptide approaches using 12-15 amino acid synthetic peptides often fail because the short sequences may not fold correctly or may represent discontinuous epitopes in the native protein that aren't captured by linear peptides. The comprehensive bioinformatic analysis pipeline used for the recombinant protein approach—involving antigenicity prediction, cross-reactivity assessment, and expression of unique protein regions—proved to be robust and can serve as a guide for future antibody projects. Additionally, the critical importance of affinity purification was demonstrated, as this step significantly improved detection rates compared to crude antisera or generic purification methods .

What is the significance of using At5g45160 antibody in the context of broader Arabidopsis research?

The At5g45160 antibody holds significant value within the broader context of Arabidopsis research by providing researchers with a specific tool to study native protein expression, localization, and interactions without relying on genetic modifications. This antibody is part of a larger collection of 94 antibodies against key Arabidopsis root proteins, representing a valuable communal resource that enables consistent, standardized protein detection across the research community. The ability to detect endogenous protein allows researchers to observe natural expression patterns and levels without the potential artifacts introduced by overexpression or fusion tags. In the post-genomics era, as research shifts toward understanding protein function and dynamics in complex cellular contexts, antibodies like this enable investigations of protein-protein interactions, subcellular localization, and changes in protein expression in response to environmental or developmental cues. The availability of validated antibodies against multiple cellular compartment markers (BiP, γ-cop, PM-ATPase, MDH) within the same collection facilitates co-localization studies to precisely determine At5g45160 subcellular distribution. Furthermore, this antibody resource supports systems biology approaches by enabling researchers to connect genomic data with protein-level observations, helping to elucidate regulatory networks and protein function in the context of cellular and tissue dynamics. The continued validation and characterization of such antibody resources by the research community will progressively enhance their utility for plant science worldwide .

What experimental design considerations should be made when comparing At5g45160 protein levels across different Arabidopsis tissues or developmental stages?

When comparing At5g45160 protein levels across different Arabidopsis tissues or developmental stages, researchers should implement a comprehensive experimental design that accounts for biological complexity and technical challenges. Sample collection should be standardized with precise developmental staging and tissue harvesting protocols to ensure comparability, ideally collecting samples at the same time of day to control for circadian variations in protein expression. Biological replication is critical, with a minimum of three independent biological replicates for statistical validity. Protein extraction methods must be optimized for each tissue type, as extraction efficiency can vary significantly between tissues due to differences in cell wall composition, secondary metabolites, and protein-to-matrix ratios. Extraction buffers should contain appropriate protease inhibitors to prevent differential degradation across samples. For quantitative Western blot analysis, researchers should identify suitable loading controls that maintain consistent expression across the tissues and developmental stages being compared. Total protein normalization methods (such as Ponceau S staining) can provide more reliable normalization than single housekeeping proteins. Standard curves using recombinant At5g45160 protein should be included to ensure detection linearity across the relevant concentration range. Statistical analysis should account for both biological and technical variability, using appropriate statistical tests to determine significance of observed differences. Finally, complementary approaches such as RT-qPCR for mRNA levels, immunohistochemistry for spatial distribution, and potentially mass spectrometry-based quantification can provide multi-level validation of observed protein expression patterns .